Share price: 104.00p

Director’s dealing

21st June 2016

The Company has been notified that on 20th June 2016 Mark Scott, the Chief Executive of the Company, sold and then re-purchased 101,525 ordinary shares of 10 pence each in the Company (“Ordinary Shares”). The Ordinary Shares were sold from Mr Scott’s personal holding and acquired through his SIPP. The sale price was 97.00p and the acquisition price was 97.03p. The sale and purchase has no effect on the total number of Ordinary Shares held by Mr Scott.

Following the purchase, Mr Scott remains beneficially and non-beneficially interested in 1,320,175 Ordinary Shares, representing 1.52 per cent. of the current issued share capital of the Company.

 

20th June 2016

 

Contact Us

Dianna Hillier

Dianna.Hillier@cellohealth.com

Phone 020 7812 8468

Address

Cello Health plc

Queens House

8-9 Queen Street

London

EC4N 1SP

Registered Office

Queens House

8-9 Queen Street

London

EC4N 1SP

Company Registered

in England no.05120150